Sotera Health (SHC) Competitors $15.78 +0.04 (+0.26%) As of 03:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHC vs. HIMS, GH, OPCH, RDNT, BTSG, SGRY, WGS, CON, PRVA, and VCYTShould you be buying Sotera Health stock or one of its competitors? The main competitors of Sotera Health include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Sotera Health vs. Its Competitors Hims & Hers Health Guardant Health Option Care Health RadNet BrightSpring Health Services Surgery Partners GeneDx Concentra Group Holdings Parent Privia Health Group Veracyte Sotera Health (NASDAQ:SHC) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability. Does the media refer more to SHC or HIMS? In the previous week, Hims & Hers Health had 77 more articles in the media than Sotera Health. MarketBeat recorded 85 mentions for Hims & Hers Health and 8 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.57 beat Hims & Hers Health's score of 0.40 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 0 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 18 Very Positive mention(s) 9 Positive mention(s) 49 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more risk & volatility, SHC or HIMS? Sotera Health has a beta of 1.81, meaning that its share price is 81% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.08, meaning that its share price is 108% more volatile than the S&P 500. Is SHC or HIMS more profitable? Hims & Hers Health has a net margin of 9.63% compared to Sotera Health's net margin of 2.14%. Sotera Health's return on equity of 39.42% beat Hims & Hers Health's return on equity.Company Net Margins Return on Equity Return on Assets Sotera Health2.14% 39.42% 5.66% Hims & Hers Health 9.63%26.26%13.06% Which has better earnings & valuation, SHC or HIMS? Hims & Hers Health has higher revenue and earnings than Sotera Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSotera Health$1.10B4.07$44.34M$0.08197.26Hims & Hers Health$1.48B6.90$126.04M$0.8056.31 Do institutionals & insiders hold more shares of SHC or HIMS? 91.0% of Sotera Health shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 55.1% of Sotera Health shares are held by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer SHC or HIMS? Sotera Health currently has a consensus target price of $16.00, suggesting a potential upside of 1.39%. Hims & Hers Health has a consensus target price of $38.92, suggesting a potential downside of 13.60%. Given Sotera Health's stronger consensus rating and higher probable upside, research analysts clearly believe Sotera Health is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sotera Health 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Hims & Hers Health 3 Sell rating(s) 7 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.92 SummarySotera Health and Hims & Hers Health tied by winning 8 of the 16 factors compared between the two stocks. Get Sotera Health News Delivered to You Automatically Sign up to receive the latest news and ratings for SHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHC vs. The Competition Export to ExcelMetricSotera HealthMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.48B$7.70B$5.71B$9.79BDividend YieldN/A2.70%3.77%4.10%P/E Ratio197.2176.8730.9125.28Price / Sales4.0731.87404.2188.50Price / Cash13.1024.1325.2228.45Price / Book11.047.929.536.01Net Income$44.34M$243.33M$3.26B$265.34M7 Day Performance12.24%4.35%4.66%2.89%1 Month Performance42.69%3.16%5.35%1.61%1 Year Performance5.42%20.66%32.14%25.61% Sotera Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHCSotera Health1.2053 of 5 stars$15.78+0.3%$16.00+1.4%+5.1%$4.48B$1.10B197.213,000Analyst UpgradeHIMSHims & Hers Health2.77 of 5 stars$49.93-3.9%$39.83-20.2%+195.8%$11.63B$1.48B62.411,637Trending NewsAnalyst ForecastGHGuardant Health3.1751 of 5 stars$54.80+1.1%$57.50+4.9%+110.7%$6.76B$739.02M-16.362,021Positive NewsOPCHOption Care Health4.6565 of 5 stars$27.85-1.2%$35.75+28.4%-9.7%$4.58B$5.00B22.288,088News CoveragePositive NewsRDNTRadNet3.3232 of 5 stars$62.00+16.2%$69.60+12.3%+4.7%$4.00B$1.83B-144.1811,021News CoveragePositive NewsAnalyst UpgradeInsider TradeHigh Trading VolumeBTSGBrightSpring Health Services2.6394 of 5 stars$20.66-0.6%$25.67+24.2%+86.8%$3.68B$11.27B66.6535,000Positive NewsSGRYSurgery Partners3.1191 of 5 stars$22.74-3.8%$33.00+45.1%-21.4%$3.03B$3.11B-15.9015,000Insider TradeWGSGeneDx1.9559 of 5 stars$110.54+5.1%$101.63-8.1%+265.5%$3.02B$305.45M2,210.801,200CONConcentra Group Holdings Parent2.3123 of 5 stars$21.47-0.7%$28.50+32.7%-0.9%$2.77B$1.90B18.0411,250PRVAPrivia Health Group3.4627 of 5 stars$20.31-1.3%$28.00+37.9%+6.9%$2.53B$1.74B184.651,140VCYTVeracyte2.9259 of 5 stars$27.99+2.3%$40.90+46.1%-8.0%$2.15B$445.76M84.82790News Coverage Related Companies and Tools Related Companies Hims & Hers Health Competitors Guardant Health Competitors Option Care Health Competitors RadNet Competitors BrightSpring Health Services Competitors Surgery Partners Competitors GeneDx Competitors Concentra Group Holdings Parent Competitors Privia Health Group Competitors Veracyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHC) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sotera Health Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Sotera Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access